TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: overall success rate of US-guided pneumatic reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain scores during removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total microbial load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Identification of landmarks on lateral cephalogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive performance (DSST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of drinking occasions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-terminal pro-hormone brain natriuretic peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Central augmented pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: consistent use of products
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of continuous abstinence at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance improvement measured by CB&M
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance improvement measured by BESTest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of responders to flecainide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QRS width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venous Filling Index (VFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venous volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to fill 90% of the venous volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3/4 neutropenia/anemia
Endpoint domain: Adverse events/effects
Primary endpoint: eNOS immunoreactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Sputum conversion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cavity-close rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak [HCO3‐]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viable bacteria quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aβ-related biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Recovery to normal CD4%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient global assessment success
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Investigator global assessment success
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medication nonadherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readmission rate to hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Changes in NYHA functional class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day morbidity
Endpoint domain: Mortality/survival
Primary endpoint: moderate-to-vigorous activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Fatigue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tampa Scale of Kinesiophobia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dysphonia Severity Index (DSI) deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vocal discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rectosigmoidal cancer mortality
Endpoint domain: Mortality/survival
Primary endpoint: Myopic sphere and spherical equivalent values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crying ratio
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: visual attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: purchase intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of hyperkalemia
Endpoint domain: Adverse events/effects
Primary endpoint: Confirmed viral load <50 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median increases in CD4 cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of percentage energy from fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in servings of fruits and vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decline in agitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in neuropsychiatric symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of anti-depressive medication
Endpoint domain: Adverse events/effects
Primary endpoint: Energy balance (EB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay in requesting help
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working memory enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Self-rated mood improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anti-PRP antibody avidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total decrease on NRS at 30 minutes after first administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DTG AUC0-τ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DTG Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DTG Cτ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the degree of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total invasive cancer risk
Endpoint domain: Mortality/survival
Primary endpoint: any cancer death risk
Endpoint domain: Mortality/survival
Primary endpoint: submaximal exercise time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of aminotransferase activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disappearance of serum HCV RNA (PCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histopathological improvement in hepatitis activity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in gene expression associated with immune pathways
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum irisin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum hs‐CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return on Investment (ROI)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: peak heart rate (HR(peak))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: peak oxygen consumption (VO(2peak))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: [La(peak)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Steady-state glucose infusion rates (SSGIRs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time taken to tracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: subjective evaluation of ease of use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: willingness to use the Glidescope in an emergency
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: One in-treatment pregnancy (Pearl Index)
Endpoint domain: Mortality/survival
Primary endpoint: Physical performance (Mini-BEST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait (FGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition (MoCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score for swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily OFF time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Probability of prescribing a recommended drug
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Soluble thrombomodulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe sepsis and septic shock incidence
Endpoint domain: Adverse events/effects
Primary endpoint: dynamic stability indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean A1C<6.5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients with 'absent' or 'very mild' disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: combined risk of nonfatal and fatal stroke
Endpoint domain: Mortality/survival
Primary endpoint: any CHD event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: private self-consciousness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 48-hour reversion rates to sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: days of fruit consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genital adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Abdominal pain or discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and tolerability of SPL7013 Gel
Endpoint domain: Adverse events/effects
Primary endpoint: tumor necrosis factor‐α levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: colony-forming units of Escherichia coli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of first episodes of clinical malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: self-efficacy for seeking social support
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: satisfaction with information about side effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: combined TIMI 2 or 3 flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: time from randomization to initial revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: swallowing impairment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent change in plaque volume (%PV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percent change in body mass index (%BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short-term depressive improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term depressive improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall corneal RMS wavefront error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical response failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with hearing aids
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage likely to purchase hearing aids
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in post-teaching MCQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Student enjoyment of simulation-based teaching
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Resource intensity of simulation-based teaching
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of root resorption on upper incisors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Induction times to loss of the eyelash reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation due to hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: absolute magnitude of benefit for adjuvant therapies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: diaphragm thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients achieving complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving delayed complete control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary events among participants
Endpoint domain: Mortality/survival
Primary endpoint: Regression from microalbuminuria or proteinuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Immunological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroprotection after vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to complete both-side CPVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First-pass isolation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LA-PV reconnection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mental component summary of health-related quality of life (HRQL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: weekly complete spontaneous bowel movement frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: straining scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Catch-up growth (birthweight regain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent periodic breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: increased proportions of CD4+ T cells which were IL‐10+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: decreased proportions of CD4+ and CD8+ T cells which were IL‐4+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Arterial blood gas analysis improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CS stent area at the sidebranch carina
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area-under-the-curve of energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleepiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caffeine terminal half-life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oropharyngeal seal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resected adenoma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: catheterization duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Breast cancer-specific survival probabilities
Endpoint domain: Mortality/survival
Primary endpoint: Postpartum Depression (PPD) prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global health/QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of bowel actions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: initial cessation at week 3
Endpoint domain: Mortality/survival
Primary endpoint: continuous abstinence throughout one year
Endpoint domain: Mortality/survival
Primary endpoint: incidence of local irritation or itching at the patch site
Endpoint domain: Adverse events/effects
Primary endpoint: patient preference for PCS over ACS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: discomfort during recovery period
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: adequacy of wound care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Stroke Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Linkage to HIV care within three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores during sheath removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean faecal residue in the resection specimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in pro-inflammatory mediator levels (IL-2, IL-6, TNF-α)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Effective healing of pressure ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Met pregnancy fruit guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation in radiation exposure from CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual effective dose per capita
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in CD4 lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hot flush subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm delivery before 34 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Compound neonatal morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neonatal outcomes
Primary endpoint: one year graft function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: serum insulin concentration change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SOT Equilibrium Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOT 2-Dimensional Sway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MCT Response Latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for optimization manoeuvres
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: sciatic leg pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Velocity of angular displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean relative MTX bioavailability (PO/SC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of response within 10 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for supplementary naloxone
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic sensitivity of ANCA detection using IALP technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic specificity of ANCA detection using IALP technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: function and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral hedonic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean frequency of registrations at blood drives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful blood donations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in best-corrected visual acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in intraocular pressure (IOP)
Endpoint domain: Adverse events/effects
Primary endpoint: Need for glaucoma medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: readiness for help-seeking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-reported success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on King's Health Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status